Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma

NCT00392340 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

63

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma

Interventions

BIOLOGICAL: filgrastim
DRUG: doxorubicin hydrochloride
DRUG: topotecan hydrochloride
DRUG: vincristine sulfate

Sponsor

Children's Cancer and Leukaemia Group